Page last updated: 2024-08-26

1,4-dihydropyridine and Head and Neck Neoplasms

1,4-dihydropyridine has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curti, C; Garcia, CB; Goto, RN; Leopoldino, AM; Lopes, NP; Marín-Prida, J; Ochoa-Rodríguez, E; Pardo-Andreu, GL; Sobral, LM; Sousa, LO; Verdecia-Reyes, Y1

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Head and Neck Neoplasms

ArticleYear
Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
    European journal of pharmacology, 2018, Jan-15, Volume: 819

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydropyridines; Gene Expression Regulation, Neoplastic; Genes, myc; Head and Neck Neoplasms; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondrial Size; Neoplasm Invasiveness; Neovascularization, Pathologic; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2018